Evidence map›Paper›PMID 22394183›Full record

ArticleNanomedicine (London, England)2012

Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions.

Emily M Plummer, Diane Thomas, Giuseppe Destito, Leah P Shriver, Marianne Manchester

Open access · greenAbstract read
In one paragraph

Article in Nanomedicine (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery.Journal of controlled release : official journal of the Controlled Release Society · 2013
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Emily M PlummerUniversity of California, San Diego, Skaggs School of Pharmacy, La Jolla, CA 92093-0749, USA.
Diane Thomas
Giuseppe Destito
Leah P Shriver
Marianne Manchester
Scripps Research Institute · USUniversity of California, San Diego · USUniversity of Montana · US

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
USING VIRAL NANOPARTICLES TO TARGET CANCERR01CA112075 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MANCHESTER, MARIANNE · 2005 to 2009
$3.7M
NCI NIH HHS R01 CA112075NCI NIH HHS R01CA112075NINDS NIH HHS P30 NS047101NINDS NIH HHS P30NS047101
6 · The paper itself

Abstract

aimsDetection of atherosclerosis has generally been limited to the late stages of development, after cardiovascular symptoms present or a clinical event occurs. One possibility for early detection is the use of functionalized nanoparticles. The aim of this study was the early imaging of atherosclerosis using nanoparticles with a natural affinity for inflammatory cells in the lesion. MATERIALS &

methodsWe investigated uptake of cowpea mosaic virus by macrophages and foam cells in vitro and correlated this with vimentin expression. We also examined the ability of cowpea mosaic virus to interact with atherosclerotic lesions in a murine model of atherosclerosis. RESULTS &

conclusionWe found that uptake of cowpea mosaic virus is increased in areas of atherosclerotic lesion. This correlated with increased surface vimentin in the lesion compared with nonlesion vasculature. In conclusion, cowpea mosaic virus and its vimentin-binding region holds potential for use as a targeting ligand for early atherosclerotic lesions, and as a probe for detecting upregulation of surface vimentin during inflammation.

Indexed as

NanoparticlesAnimalsArteriesAtherosclerosisCell LineCells, CulturedComovirusEndothelial CellsFoam CellsLipoproteins, LDLMacrophagesMaleMiceMice, Inbred C57BLPlaque, AtheroscleroticVimentinLipoproteins, LDLoxidized low density lipoproteinVimentin

Identifiers

PMID22394183
PMCPMC3567616
OpenAlexW2062784215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.